Department of Urology, Institute of Urology, Anhui Province Key Laboratory of Genitourinary Diseases, The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, 230022, China.
Department of Urology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan, Hubei Province, 430022, China.
J Exp Clin Cancer Res. 2024 Jan 23;43(1):29. doi: 10.1186/s13046-023-02940-6.
The VHL-HIF pathway and lipid droplet accumulation are the main characteristics of clear cell renal cell carcinoma (ccRCC). However, the connection between the two features is largely unknown.
We used transcriptional sequencing and TCGA database analysis to identify APOL1 as a novel therapeutic target for ccRCC. The oncogenic functions of APOL1 were investigated by cell proliferation, colony formation, migration and invasion assays in ccRCC cells in vitro and xenografts derived from ccRCC cells in vivo. Oil red O staining and quantification were used to detect lipid droplets. Chromatin immunoprecipitation (ChIP) assays and luciferase reporter assays were carried out to identify HIF-2α bound to the promoter of APOL1 and lncRNA LINC02609. RNA-FISH and luciferase reporter assays were performed to determine that LncRNA LINC02609 functions as a competing endogenous RNA to regulate APOL1 expression by sponging miR-149-5p.
RNA-seq data revealed that HIF2α can regulate APOL1 and lncRNA LINC02609 expression. We also found that HIF-2α can bind to the promoter of APOL1 and lncRNA LINC02609 and transcriptionally regulate their expression directly. We further demonstrated that LncRNA LINC02609 functions as a competing endogenous RNA to regulate APOL1 expression by sponging miR-149-5p in ccRCC. Mechanistically, APOL1-dependent lipid storage is required for endoplasmic reticulum (ER) homeostasis and cell viability and metastasis in ccRCC. We also showed that high APOL1 expression correlated with worse clinical outcomes, and knockdown of APOL1 inhibited tumor cell lipid droplet formation, proliferation, metastasis and xenograft tumor formation abilities. Together, our studies identify that HIF2α can regulate the expression of the lipid metabolism related gene APOL1 by direct and indirect means, which are essential for ccRCC tumorigenesis.
Based on the experimental data, in ccRCC, the HIF-2α/LINC02609/APOL1 axis can regulate the expression of APOL1, thus interfering with lipid storage, promoting endoplasmic reticulum homeostasis and regulating tumor progression in ccRCC. Together, our findings provide potential biomarkers and novel therapeutic targets for future studies in ccRCC.
VHL-HIF 通路和脂滴积累是透明细胞肾细胞癌(ccRCC)的主要特征。然而,这两个特征之间的联系在很大程度上尚不清楚。
我们使用转录组测序和 TCGA 数据库分析鉴定 APOL1 是 ccRCC 的一种新的治疗靶点。通过体外 ccRCC 细胞增殖、集落形成、迁移和侵袭实验以及体内 ccRCC 细胞来源的异种移植物研究了 APOL1 的致癌功能。油红 O 染色和定量用于检测脂滴。进行染色质免疫沉淀(ChIP)实验和荧光素酶报告基因实验以鉴定 HIF-2α 结合到 APOL1 和 lncRNA LINC02609 的启动子上。进行 RNA-FISH 和荧光素酶报告基因实验以确定 LncRNA LINC02609 作为竞争性内源性 RNA 通过海绵吸附 miR-149-5p 来调节 APOL1 的表达。
RNA-seq 数据显示 HIF2α 可以调节 APOL1 和 lncRNA LINC02609 的表达。我们还发现 HIF-2α 可以结合到 APOL1 和 lncRNA LINC02609 的启动子上,并直接转录调节它们的表达。我们进一步证明 LncRNA LINC02609 通过海绵吸附 miR-149-5p 作为竞争性内源性 RNA 来调节 ccRCC 中的 APOL1 表达。在机制上,APOL1 依赖性脂滴储存对于 ccRCC 中的内质网(ER)稳态和细胞活力以及转移是必需的。我们还表明,APOL1 高表达与更差的临床结局相关,而 APOL1 的敲低抑制了肿瘤细胞脂滴形成、增殖、转移和异种移植物肿瘤形成能力。总之,我们的研究表明 HIF2α 可以通过直接和间接的方式调节与脂质代谢相关的基因 APOL1 的表达,这对于 ccRCC 的肿瘤发生是必不可少的。
基于实验数据,在 ccRCC 中,HIF-2α/LINC02609/APOL1 轴可以调节 APOL1 的表达,从而干扰脂滴储存,促进内质网稳态并调节 ccRCC 中的肿瘤进展。总之,我们的发现为未来 ccRCC 的研究提供了潜在的生物标志物和新的治疗靶点。